Narrow-band UVB combined with compound clobetasol propionate can improve the therapeutic effect in hand eczema patients

摘要

Objective: To explore the therapeutic effect of narrow-band UVB combined with compound clobetasol propionate on hand eczema patients. Methods: From June 2017 to June 2020, 102 patients with hand eczema in our hospital were recruited for this study and divided into group A (GA) and group B (GB). The 50 patients in GA were treated with narrow-band UVB irradiation only, and the 52 patients in GB were treated with compound clobetasol propionate in addition to the treatment administered to GA. The patients’ general data and therapeutic effects were observed in both groups. The adverse reactions were also observed during the treatment. The severity index scores (EASI) of the pruritus and eczema areas of the skin lesions were observed before and after the therapy. The IFN-γ and IL-4 levels in the serum were tested using ELISA. After the therapy, the quality of life and any recurrences within 3 months were observed in both groups. Results: There were no differences in the baseline data between the two groups (P0.05). The curative effect in GB was better than it was in GA (P0.05). The incidence of adverse reactions in GB was significantly lower than the incidence in GA (P0.05). After the therapy, the EASI scores of the pruritus and eczema areas of the skin lesions in GB were significantly lower than they were in GA (P0.05). After the therapy, the patients’ serum IFN-γ and IL-4 levels in GB were significantly better than they were in GA. After the therapy, the quality of life of the patients in GB was significantly higher than it was in in GA (P0.05). After 3 months of therapy, the recurrence rate in GB was significantly lower than it was in GA (P0.05). Conclusion: Narrow-band UVB combined with compound clobetasol propionate is effective at treating patients with hand eczema, as it can effectively improve their clinical symptoms and is very safe.